NCT01937026View on ClinicalTrials.gov

A Study of Baricitinib and Probenecid in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Baricitinib

Administered orally

DRUG

Probenecid

Administered orally

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01937026 - A Study of Baricitinib and Probenecid in Healthy Participants | Biotech Hunter | Biotech Hunter